Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation

Onishi, Nobuyuki; Kyo, Shokan; Oi, Maki; Jinnai, Toshikazu; Kuroda, Maiko; Shimizu, Yukiko; Imamura, Sari; Harita, Takeshi; Nishiuchi, Suguru; Hanazawa, Koji; Tamura, Toshihiro; Izumi, Chisato; Nakagawa, Yoshihisa; Kaitani, Kazuaki

doi:10.1002/joa3.12457

Cited by 7 publications

(4 citation statements)

References 38 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinical trials on intervention treatment strategies (rate or rhythm control) demonstrated lower HRQoL values for patients with AF compared to the general population or control groups [24,25]. The effect of the use of ablation [26] and cardioversion [27] on the sense of quality of life in AF has also been documented.…”

Section: Discussionmentioning

confidence: 99%

Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation

Lomper

Ross

Uchmanowicz

2023

IJERPH

View full text Add to dashboard Cite

Introduction: Symptoms of atrial fibrillation (AF) can significantly affect functioning in daily life and reduce patients’ quality of life (QoL). The severity and type of AF symptoms affects not only patient’s QoL, but can be a cause of the development of emotional and psychological disorders. In addition, frailty syndrome (FS) plays important role from the point of view of developing disability and dependence on others, as well as reducing QoL. Aim: To assess the symptoms of anxiety and depression, to evaluate the co-occurrence of frailty syndrome and the impact of these factors on the quality of life of patients with AF. Methods: The study used a Polish adaptation of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia part III (ASTA part III), the Tilburg Frailty Indicator (TFI) and the Hospital Anxiety Depression Scale (HADS). Results: Analysis showed that anxiety symptoms and depressive symptoms correlate significantly (p˂0.05) and positively with the physical (r = 0.24; p < 0.001, r = 0.29, p = 0.002, respectively), psychological (r = 0.34, p < 0.001, r = 0.49 p < 0.001, respectively) and total quality of life (r = 0.31, p = 0.001, r = 0.414; p < 0.001, respectively) ASTA III domains. A significant (p˂0.05) positive correlation was observed between the TFI total score and the physical (r = 0.34, p < 0.001), psychological (r = 0.36, p < 0.001) and overall quality of life (r = 0.38, p < 0.001) in ASTA III domains. Conclusions: Both FS and depressive and anxiety symptoms significantly affect QoL. Understanding the relationship between anxiety and depressive symptoms, FS and QoL may allow for a more targeted approach to the treatment and care of patients with AF.

show abstract

Section: Discussionmentioning

confidence: 99%

Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation

Lomper

Ross

Uchmanowicz

2023

IJERPH

View full text Add to dashboard Cite

show abstract

“…A recent study has shown that catheter ablation makes asymptomatic atrial fibrillation patients more healthconscious, which leads to better medication adherence, lower salt-sensitive hypertension, and thus improved cardiac function. It also reduced mental anxiety and activity limits, which helped improve the quality of life (73). However, another study suggests that anxiety and depression in patients with the acute coronary syndrome who underwent PCI were associated with increased length of hospital stay (74).…”

Section: Discussionmentioning

confidence: 99%

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021

You

Shou

Fan

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

The aim of this study was to gain insight into the progress and dynamics of psycho-cardiological disease research and track its hot spots. We have analyzed psycho-cardiological disease-related literature extracted from the Web of Science (WOS) Core Collection from 2001 to 2021 with the help of Cite Space. As a result, we have included 5,032 records. Then, we have analyzed connected networks for the country, author, subject category, keywords, and cited reference. We have summarized the findings in four aspects. First, the annual quantitative distribution of publications is on the rise, although there is a slight drop. Second, in terms of country analysis, the United States, England, Australia, Germany, and Italy are the main research forces in psycho-cardiological diseases. At the same time, several academic entities represented by Andrew Steptoe and Roland von Känel, MD, have been formed based on the early consciousness of physical and mental health in these countries. Besides, China is also more concerned about it due to the rapid population aging process and the largest population. Third, the psycho-cardiological disease is multidisciplinary, including psychology, psychiatry, clinical medicine, such as cardiovascular system and neurology, public environmental and occupational health, and pharmacology. Finally, the results of keyword analysis and co-cited references indicate the hot spots and frontiers in psycho-cardiological disease. The hot spots in psycho-cardiological disease include three aspects. The first aspect includes psychosocial factors, such as depression, lack of social support, and low economic and social status; the second aspect includes priority populations, such as Alzheimer’s disease dementia caregivers, elderly, and patients with cancer, and the third aspect includes interventions, such as exercise therapy and diet. In addition, there are three future research frontiers. The first is a psycho-cardiological disease in patients with COVID-19; the second is cardiac rehabilitation, especially exercise therapy and health behavior evaluation; and the final is evidence-based medical evaluation, such as systematic reviews and meta-analyses.

show abstract

“…If assessed in more detail, such as using validated questionnaires, AF-related symptoms could be found (or compared). Therefore, several reports have documented improvements in QoL, as assessed using a standardized questionnaire, after CA of asymptomatic persistent AF patients 38,39 . Even though current ESC guidelines remain restrictive with their recommendations on CA for non-paroxysmal AF, these patients seem to benefit more from the procedure than paroxysmal patients.…”

Section: The Effect Of Catheter Ablation On Quality Of Life In Non-pa...mentioning

confidence: 99%

Catheter ablation for non-paroxysmal atrial fibrillation. A review

Hassouna,

Osmancik

2024

BIOMED PAP

View full text Add to dashboard Cite

Atrial fibrillation (AF), the most common cardiac arrhythmia is associated with increased morbidity and mortality. The higher mortality is due to the risk of heart failure and cardioembolic events. This in-depth review focuses on the strategies and efficacy of catheter ablation for non-paroxysmal atrial fibrillation. The main medical databases were searched for contemporary studies on catheter ablation for non-paroxysmal AF. Catheter ablation is currently proven to be the most effective treatment for AF and consists of pulmonary vein isolation as the cornerstone plus additional ablations. In terms of SR maintenance, it is less effective in non-paroxysmal AF than in paroxysmal patients. but the clinical benefit in non-paroxysmal patients is substantially higher. Since pulmonary vein isolation is ineffective, a variety of techniques have been developed, e.g. linear ablations, ablation of complex atrial fractionated electrograms, etc. Another paradox consists in the technique of catheter ablation. Despite promising results in early observation studies, further randomized studies have not confirmed the initial enthusiasm. Recently, a new approach, pulsed-field ablation, appears promising This is an in-depth summary of current technologies and techniques for the ablation of non-paroxysmal AF. We discuss the benefits, risks and implications in the treatment of patients with non-paroxysmal AF.

show abstract

Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Cited by 7 publications

References 38 publications

Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation

Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021

Catheter ablation for non-paroxysmal atrial fibrillation. A review

Contact Info

Product

Resources

About